Equibles does not estimate personal net worth.
Get an email with a short summary when Baxter International Inc publishes a filing, an earnings call transcript or a press release.
Get BAX alertsBrent Shafer is recorded as Chairman at Baxter International Inc (BAX) since February 3, 2025 and CEO at Baxter International Inc (BAX). The newest filing on record that lists Brent Shafer as CEO at Baxter International Inc (BAX) is dated March 23, 2026. Baxter International Inc reported in an 8-K filed May 8, 2026 that Brent Shafer was appointed director, effective May 5, 2026. Baxter International Inc reported in an 8-K filed February 3, 2025 that Brent Shafer resigned as lead independent director. Baxter International Inc reported in an 8-K filed February 3, 2025 that Brent Shafer was appointed interim CEO of the Company, effective February 3, 2025. Equibles holds 4 filed executive changes naming Brent Shafer; each is listed under recent activity with its source filing. The proxy statement of Baxter International Inc reports total compensation of $3,809,993 for Brent Shafer in fiscal 2025, including a base salary of $701,644. Brent Shafer has spoken on 2 earnings calls across 1 company, most recently for Baxter International Inc on May 1, 2025. Baxter International Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Baxter International Inc includes Andrew Hider (CEO, CFO and Board Member), José Almeida (CEO), Anita Zielinski (CFO and Chief Accounting Officer) and 7 others.
“The nine nominees for director were elected as follows: | Nominee | For | | Against | | Abstain | | BrokerNon-Votes | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Brent Shafer | | 430,536,987 | | 10,050,968 | | 279,456 | | 42,556,435 |”
“In conjunction with his appointment, Brent Shafer is stepping down from his role as lead independent director.”
“Our results for the first quarter reflect the building momentum of our strategic transformation journey and the hard work of our Baxter colleagues globally.”
“As you know, I recently stepped into the role of chair. Joel Ameda led the business through a period and we're sincerely grateful for it. One of the board's top priorities, of course, is the identification.”
2025-02-03–present
Start not stated–present
Last confirmed March 23, 2026
2022-01-01–2025-03-25
Last confirmed by a filing; no departure on record
2022-01-01–2025-02-03
Medical Instruments & Supplies · Healthcare
CEO, Chairman
2022-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Baxter International Inc (BAX) | Non-Executive Chair and Former Executive Chair and Interim CEO | $701,644 | $3,809,993 |
